Arno Therapeutics, Inc.
ARNI · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Market Cap | $7 | $14 | $21 | $18 |
| - Cash | $0 | $8 | $27 | $11 |
| + Debt | $2 | $0 | $0 | $0 |
| Enterprise Value | $9 | $6 | -$6 | $8 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$13 | -$21 | -$17 | -$14 |
| % Margin | – | – | – | – |
| Net Income | -$12 | $8 | -$58 | -$21 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.57 | 0.31 | -7.75 | -4.57 |
| % Growth | -283.9% | 104% | -69.6% | – |
| Operating Cash Flow | -$10 | -$19 | -$14 | -$9 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$10 | -$19 | -$14 | -$9 |